Pfizer to ask FDA for emergency use of its COVID-19 vaccine in U.S.
FDA approval could result in vaccine doses becoming ready as early as December
Pharmaceutical company Pfizer said Friday it is asking federal regulators to allow emergency use of its COVID-19 vaccine.
Pfizer will make the request days after saying the company and German partner BioNTech's vaccine appeared to be 95% effective at the virus in late-stage clinical trials, according to the Associated Press.
The Food and Drug Administration can sometimes grant emergency-use authorization, before the final testing is fully complete.
News, Not Noise
- Group files emergency petition in Wisconsin after finding 150,000 potentially fraudulent ballots
- Sidney Powell plans to file Georgia election-related lawsuit 'no later than tomorrow'
- Trump team wins hearings in Arizona, Michigan and Pennsylvania legislatures on election concerns
- Trump campaign adviser: DOJ 'asleep at the wheel' amid systemic election fraud allegations
- Media said Trump's COVID-19 vaccine prediction would take 'miracle.' They were wrong.